Cargando…
The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidence
The incidence of pancreatic neuroendocrine tumors (panNETs) has increased worldwide in the last two decades. Given the indolent nature of these tumors, several patients are diagnosed with metastatic disease, which partially impairs the long-term efficacy of currently available treatments and reduces...
Autores principales: | Pusceddu, Sara, Vernieri, Claudio, Prinzi, Natalie, Torchio, Martina, Coppa, Jorgelina, Antista, Maria, Niger, Monica, Milione, Massimo, Giacomelli, Luca, Corti, Francesca, Prisciandaro, Michele, Monteleone, Michela, Colombo, Elena, Di Bartolomeo, Maria, de Braud, Filppo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406937/ https://www.ncbi.nlm.nih.gov/pubmed/32821286 http://dx.doi.org/10.1177/1756284820927271 |
Ejemplares similares
-
Impact of Diabetes and Metformin Use on Enteropancreatic Neuroendocrine Tumors: Post Hoc Analysis of the CLARINET Study
por: Pusceddu, Sara, et al.
Publicado: (2021) -
Differential Diagnosis and Management of Diarrhea in Patients with Neuroendocrine Tumors
por: Pusceddu, Sara, et al.
Publicado: (2020) -
One size does not fit all for pancreatic cancers: A review on rare histologies and therapeutic approaches
por: Niger, Monica, et al.
Publicado: (2020) -
Biomarker Landscape in Neuroendocrine Tumors With High-Grade Features: Current Knowledge and Future Perspective
por: Prisciandaro, Michele, et al.
Publicado: (2022) -
Case Report: Exceptional Response to Avelumab After Failure of Electrochemotherapy in a Patient With Rapidly Progressive, PD-L1-Negative Merkel Cell Carcinoma
por: Torchio, Martina, et al.
Publicado: (2021)